Target N. V. Biotech, 10% Owner at Radius Health, Inc. (RDUS), bought 850,000 shares at $6.30 ($5.4M) on 2022-01-05, disclosed to the SEC on 2022-01-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.30 | 250,000 | $1.6M | 29.4% |
| 2 | $6.31 | 300,000 | $1.9M | 35.3% |
| 3 | $6.31 | 300,000 | $1.9M | 35.3% |
| Total | $6.31 avg | 850,000 | $5.4M | 100% |
| Filing → |
| MGNX | BUY | 2023-01-23 | $795K | — | Filing → |
| MGNX | BUY | 2022-11-25 | $1.8M | — | Filing → |
| MTEM | BUY | 2022-05-18 | $236K | — | Filing → |